Elad Jacoby

St. Louis Children's Hospital — United States

Medicine · Health Sciences

31h-index5.1kcitations165works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(111), Virus-based gene therapy research(21), Viral Infectious Diseases and Gene Expression in Insects(20), Acute Lymphoblastic Leukemia research(17), Immune Cell Function and Interaction(15)

Publications165 total

P-486. Implementation of a Proactive and Standardized Approach to Isolation Discontinuation and Survey of Outcomes (IP-SAID-SO)
Open Forum Infectious Diseases·2026Open Access
Point of care anti-CD19 CAR-T for autoimmune diseases
Blood·2025Open Access
A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis
Genes·2025Open Access
Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement
HemaSphere·2025Open Access
CAR T-cells dysfunction in the central nervous system is mediated by BBB-induced activation-induced cell death
2025Open Access
Neuroimaging characteristics of single Large-Scale mitochondrial DNA deletion syndromes
Neuroradiology·2025
Relapsed acute lymphoblastic leukemia: back to the drawing board
Haematologica·2025Open Access
705 | POINT OF CARE ANTI‐CD19 CART CELLS FOR PRIMARY AND SECONDARY CNS LYMPHOMA—THE EXPERIENCE OF A SINGLE CENTER COHORT
Hematological Oncology·2025Open Access
Impact of a Central Line Resource Nurse to Reduce Central Line-Associated Bloodstream Infections on a Stem Cell Transplant/Oncology Unit
American Journal of Infection Control·2025
Real world manufacturing outcomes of automated cell therapy production on the Lonza Cocoon® Platform in a phase 2 clinical trial
Cytotherapy·2025
CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma
Bone Marrow Transplantation·2025Open Access
Abstract 6107: Tailoring mRNA expression in T-cell therapy: advancing CAR-T functional optimization
Cancer Research·2025
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
Blood·2025· 16 citedOpen Access
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
Nature Medicine·2025· 22 citedOpen Access
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
The Lancet Oncology·2025· 5 citedOpen Access
Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial <scp>DNA</scp> Deletion Syndromes
Acta Paediatrica·2025· 1 citedOpen Access
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Annals of the Rheumatic Diseases·2025· 19 cited
Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults
Pediatric Blood & Cancer·2025· 1 cited
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells
Blood Advances·2025· 3 citedOpen Access
Comparable Outcomes of Point-of-Care and Commercial CD19 CAR-T Therapies: A Patient-Matched Analysis in Large B-Cell Lymphoma
Blood·2024· 1 cited
page 1 of 9Next →

Frequent Co-authors

Michal J. Besser(21), Arnon Nagler(17), Amos Toren(15), Abraham Avigdor(14), Avichai Shimoni(13), Orit Itzhaki(10), Bella Bielorai(9), Jacob Schachter(9), Terry J. Fry(7), Ivetta Danylesko(7), Ronit Yerushalmi(7), Roni Shouval(7), Shalev Fried(6), Miguel‐Angel Perales(6), Noga Shem‐Tov(6), Amilia Meir(5), Franco Locatelli(5), Stephan A. Grupp(4), Yinmeng Yang(4), Christopher D. Chien(4)